Zhejiang Tailin Bioengineering Co., Ltd. announced the withdrawal of its application to issue convertible corporate bonds to unspecified investors, and the Shenzhen Stock Exchange has decided to terminate the review of the application. The company held a board meeting on August 14, 2026, approving the termination of the issuance and the withdrawal of application documents, and subsequently submitted the withdrawal application to the Shenzhen Stock Exchange together with its sponsor, Great Wall Securities. In accordance with relevant regulations, the Shenzhen Stock Exchange formally issued a decision to terminate the review on August 24, 2026.
Zhejiang Tailin Bioengineering Co LtdCompany withdraws convertible bond issuance, terminating planned financing.
